The Unrealized Power of Digital Therapeutics
Exploring the top 3 reasons that digital therapeutics are desired and the top 3 barriers to access We live in an era of fast-paced innovation to help optimize patient outcomes and…
Blog
: General
Biomarker [Download]
Education Resources This resource was compiled in partnership with leading patient advocacy partners who participated in Foundation Medicine’s 2023 Patient Advocacy Summit. These organizations have tirelessly contributed to improving the…
The Unsung Heroes of Healthcare: Community Health Workers
As industry and advocacy organizations consider methods for engaging with more diverse, historically inaccessible audiences, consider the possibility of engagement with community health workers (CHWs) and CHW organizations. In recent…
How Do You Really Advance Diversity in Clinical Trials?
Blog by Monique French, MPH, Senior Director, Patient Advocacy, Health Policy & Communications, at Rx4good I recently attended the 2nd Diversity in Clinical Trials Summit, where leaders across the pharmaceutical…
The New Era of Diversity Action Plans: Why Integrating Patient Advocacy into Early Clinical Development Is More Essential Than Ever
Consider this: Black Americans account for about 13% of the US population and 22% of yearly cancer cases, but the median enrollment of Black Americans in clinical trials was about 4.5%,…
